Profile data is unavailable for this security.
About the company
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
- Revenue in JPY (TTM)65.86bn
- Net income in JPY10.58bn
- Incorporated1946
- Employees1.83k
- LocationKissei Pharmaceutical Co Ltd19-48, YoshinoMATSUMOTO-SHI 399-8710JapanJPN
- Phone+81 263259081
- Fax+81 263257899
- Websitehttp://www.kissei.co.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiken Chemical Co Ltd | 45.03bn | 6.54bn | 71.06bn | 745.00 | 9.30 | 1.23 | 10.08 | 1.58 | 175.57 | 175.57 | 1,208.08 | 1,329.46 | 0.7061 | 2.79 | 3.38 | 60,436,240.00 | 10.26 | 8.28 | 12.80 | 10.85 | 48.98 | 45.35 | 14.54 | 11.04 | 2.43 | -- | 0.0575 | 31.27 | 11.20 | 5.26 | 23.28 | 16.34 | 20.51 | 15.33 |
| TORII PHARMACEUTICAL CO., LTD. | 48.87bn | 3.99bn | 87.55bn | 560.00 | 21.40 | 0.7223 | 19.71 | 1.79 | 142.09 | 142.09 | 1,739.26 | 4,209.04 | 0.3782 | 2.73 | 2.41 | 87,258,930.00 | 3.09 | 6.82 | 3.37 | 7.85 | 49.14 | 51.06 | 8.17 | 15.53 | 8.03 | -- | 0.00 | 16.78 | 12.68 | -4.84 | -3.46 | 3.51 | -13.22 | 0.00 |
| Shin Nippon Biomedical Laboratories Ltd | 20.14bn | 8.04bn | 96.92bn | 994.00 | 12.05 | 3.89 | 10.29 | 4.81 | 193.21 | 193.21 | 483.67 | 597.85 | 0.4299 | 1.62 | 6.73 | 20,257,290.00 | 17.21 | 5.06 | 25.22 | 7.65 | 53.50 | 45.48 | 40.03 | 14.97 | 0.9142 | -- | 0.4231 | 24.13 | 17.46 | 0.5778 | 94.65 | -- | 9.71 | -- |
| TOWA PHARMACEUTICAL CO., LTD | 173.86bn | 9.36bn | 104.68bn | 4.08k | 10.89 | 0.7209 | 4.48 | 0.6021 | 186.62 | 186.62 | 3,473.48 | 2,818.59 | 0.5752 | 1.45 | 3.68 | 42,633,890.00 | 3.10 | 5.90 | 4.33 | 7.84 | 39.10 | 44.12 | 5.39 | 10.22 | 0.8056 | -- | 0.518 | 16.48 | 6.92 | 14.28 | 14.01 | 23.34 | -8.50 | 12.47 |
| KYORIN Holdings, Inc. | 105.53bn | 5.05bn | 111.06bn | 2.22k | 19.49 | 0.7897 | 12.56 | 1.05 | 88.18 | 88.18 | 1,841.56 | 2,176.73 | 0.621 | 1.30 | 3.04 | 47,491,000.00 | 2.97 | 3.33 | 3.66 | 4.03 | 46.13 | 51.06 | 4.79 | 5.46 | 1.87 | -- | 0.1443 | 70.59 | 2.56 | -1.77 | -35.86 | -11.65 | 0.338 | -2.16 |
| Zeria Pharmaceutical Co Ltd | 64.64bn | 5.84bn | 113.94bn | 1.74k | 16.34 | 1.54 | 9.98 | 1.76 | 131.27 | 131.27 | 1,450.17 | 1,395.01 | 0.5009 | 1.46 | 3.79 | 37,213,090.00 | 4.54 | 3.10 | 7.27 | 4.98 | 71.69 | 71.28 | 9.07 | 5.92 | 0.7455 | 6.65 | 0.4665 | 45.87 | 12.84 | -1.70 | 26.03 | 2.25 | -17.52 | 1.81 |
| Kissei Pharmaceutical Co Ltd | 65.86bn | 10.58bn | 131.24bn | 1.83k | 11.04 | 0.5838 | 8.96 | 1.99 | 229.45 | 229.45 | 1,428.10 | 4,338.62 | 0.2718 | 1.75 | 3.00 | 36,026,800.00 | 4.41 | 3.16 | 4.79 | 3.42 | 48.53 | 55.98 | 16.23 | 10.45 | 4.82 | -- | 0.0079 | 34.12 | -5.31 | -1.83 | 144.48 | 10.83 | -5.39 | 4.01 |
| Mochida Pharmaceutical Co Ltd | 109.37bn | 9.58bn | 138.35bn | 1.54k | 13.63 | 0.9943 | 11.31 | 1.26 | 252.77 | 252.77 | 2,899.75 | 3,464.88 | 0.678 | 2.24 | 3.58 | 70,835,500.00 | 5.94 | 5.22 | 7.12 | 6.40 | 53.99 | 51.57 | 8.75 | 7.76 | 3.62 | -- | 0.00 | 40.56 | 6.98 | 2.51 | 23.08 | 4.39 | 21.99 | 3.04 |
| KAKEN PHARMACEUTICAL CO., LTD. | 75.27bn | 8.79bn | 172.50bn | 1.16k | 16.11 | 1.01 | 15.28 | 2.29 | 233.13 | 233.13 | 1,994.15 | 3,730.82 | 0.4522 | 2.06 | 3.65 | 64,660,650.00 | 5.28 | 10.15 | 6.03 | 12.06 | 54.43 | 56.09 | 11.68 | 18.28 | 5.04 | -- | 0.0267 | 37.00 | 1.41 | -5.61 | -28.77 | -15.39 | 6.71 | 0.00 |
| Sawai Group Holdings Co Ltd | 192.93bn | -31.03bn | 174.73bn | 2.97k | -- | 0.8639 | -- | 0.9057 | -709.06 | -709.06 | 4,400.23 | 4,618.62 | 0.4943 | 1.48 | 2.88 | 65,002,360.00 | -11.39 | 1.25 | -15.97 | 1.70 | 31.76 | 38.97 | -23.05 | 2.46 | 1.24 | -155.68 | 0.2585 | 76.82 | 3.52 | 7.92 | -329.08 | -- | 4.38 | 0.00 |
Data as of Jan 31 2023. Currency figures normalised to Kissei Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
10.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 30 Dec 2022 | 913.30k | 1.76% |
| JPMorgan Asset Management (Japan) Ltd.as of 31 Dec 2022 | 888.80k | 1.72% |
| The Vanguard Group, Inc.as of 05 Jan 2023 | 849.96k | 1.64% |
| BlackRock Fund Advisorsas of 05 Jan 2023 | 453.00k | 0.87% |
| Baillie Gifford & Co.as of 31 Oct 2022 | 443.10k | 0.86% |
| Nikko Asset Management Co., Ltd.as of 06 Jan 2023 | 427.00k | 0.82% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2022 | 419.80k | 0.81% |
| Dimensional Fund Advisors LPas of 31 Dec 2022 | 410.51k | 0.79% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 347.40k | 0.67% |
| Brandes Investment Partners LPas of 26 Jan 2023 | 327.70k | 0.63% |
More ▼
Data from 31 Dec 2021 - 31 Dec 2022Source: FactSet Research Systems Inc.
